Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), QUALCOMM, Inc.
Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), Apple Inc.
By Sarah Roden Gilead Sciences (NASDAQ: GILD) released first quarter 2015 earnings on April 30. High revenues pointed to the success of Gilead’s …
Gilead Sciences, Inc.’s (NASDAQ:GILD) first-quarter earnings (including stock-based compensation expenses) of $2.
Gilead Sciences, Inc. (NASDAQ:GILD) and Visa Inc (NYSE:V) released the earnings reports from their most recently completed quarters after closing bell tonight.
Cowen’s healthcare analyst Phil Nadeau weighed in today with a favorable report on Gilead Sciences, Inc. (NASDAQ:GILD), following the release of Gilead’s first-quarter earnings report, showing HCV revenue …
Gilead Sciences, Inc. (NASDAQ:GILD) has been reiterated as a Buy at Needham by research analyst Alan Carr in a recent report released today.
J.P.
Gilead Sciences, Inc. (NASDAQ:GILD) blew past analyst expectations in the first quarter, reporting $7.
Gilead Sciences, Inc. (NASDAQ:GILD) has been rolling in the money since the release of its hepatitis C drug duo, Sovaldi and Harvoni.
